Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

Licences of 18 pharma firms cancelled for manufacturing spurious drugs, 26 issued show-cause notices

by AIP Online Bureau | Mar 28, 2023 | Health, Indian News

An official source said that the action has been taken against 76 companies in the first phase of a special drive against the manufacture of spurious drugs New Delhi: In a major crackdown against the manufacture of substandard drugs, central and state regulators...

Recent Posts

  • Ukraine may provide additional insurance cover for ships to revive seaborne food exports
  • Financial fragmentation could amplify shocks across global insurance markets: Geneva Association report
  • Aon launches CyQu marketplace for better cyber risk management
  • LIC leads $703mn NSE anchor book
  • Florida Hurricane could trigger $300bn insured losses: Swiss Re

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy